Lecanemab for mild Alzheimer disease – is there a way forward?

Rajesh R Tampi

Article Type

Editorial

Published

This Editorial reviews data on the efficacy and adverse effects of lecanemab amongst individuals with mild Alzheimer disease. The need for discussions regarding this medication as well as the importance of developing guidelines for use are also highlighted.

Read more

Understanding treatment goals and their application in clinical trial design for patients with Alzheimer disease and caregivers

David Gómez-Ulloa, M Chris Runken, Wilton I Rodriguez, Basilio Hernández, Montserrat Chivite, E Anne Davis, Paul Nisbet

Article Type

Original Research

Published

The goal of the present study was to survey patients with AD and caregivers to establish what they considered to be the most important treatment goals, thereby providing data for the systematic incorporation of these goals into Alzheimer disease clinical trials.

Read more

SAFE – Home Opioid Management Education (SAFE-HOME) in older adults: a naloxone awareness program for home health workers

Brianna M McQuade, Mike Koronkowski, Erin Emery-Tiburcio, Robyn Golden, Jennie B Jarrett

Article Type

Original Research

Published

This article discusses the SAFE – Home Opioid Management Education (SAFE-HOME) naloxone awareness program for older adults which utilizes home health workers to educate older adults who are prescribed opioid medications about the access to and use of naloxone to reverse opioid overdose.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.